Central Nervous System Complications after Allogeneic Hematopoietic Stem Cell Transplantation: Incidence, Manifestations, and Clinical Significance

Biology of Blood and Marrow Transplantation - Tập 13 - Trang 1369-1379 - 2007
Deborah Siegal1, Anne Keller2, Wei Xu3, Sandeep Bhuta2, Dong Hwan Kim1, John Kuruvilla1, Jeffrey H. Lipton1, Hans Messner1, Vikas Gupta1
1Blood and Marrow Transplant Program, University Health Network, Toronto, Canada
2Department of Radiology, University Health Network, Toronto, Canada
3Department of Biostatistics, Princess Margaret Hospital, University of Toronto, Toronto, Canada

Tài liệu tham khảo

Antonini, 1998, Early neurologic complications following allogeneic bone marrow transplant for leukemia: a prospective study, Neurology, 50, 1441, 10.1212/WNL.50.5.1441

de Brabander, 2000, Increased incidence of neurological complications in patients receiving an allogenic bone marrow transplantation from alternative donors, J Neurol Neurosurg Psychiatry, 68, 36, 10.1136/jnnp.68.1.36

Faraci, 2002, Severe neurologic complications after hematopoietic stem cell transplantation in children, Neurology, 59, 1895, 10.1212/01.WNL.0000036608.42104.B9

Gallardo, 1996, Neurologic complications after allogeneic bone marrow transplantation, Bone Marrow Transplant, 18, 1135

Graus, 1996, Neurologic complications of autologous and allogeneic bone marrow transplantation in patients with leukemia: a comparative study, Neurology, 46, 1004, 10.1212/WNL.46.4.1004

Guerrero, 1999, Neurological complications after autologous stem cell transplantation, Eur Neurol, 41, 48, 10.1159/000007998

Iguchi, 1999, Neurological complications after stem cell transplantation in childhood, Bone Marrow Transplant, 24, 647, 10.1038/sj.bmt.1701969

Kishi, 2004, Early central nervous system complications after reduced-intensity stem cell transplantation, Biol Blood Marrow Transplant, 10, 561, 10.1016/j.bbmt.2004.05.004

Reece, 1991, Neurologic complications in allogeneic bone marrow transplant patients receiving cyclosporin, Bone Marrow Transplant, 8, 393

Sostak, 2003, Prospective evaluation of neurological complications after allogeneic bone marrow transplantation, Neurology, 60, 842, 10.1212/01.WNL.0000046522.38465.79

Uckan, 2005, Life-threatening neurological complications after bone marrow transplantation in children, Bone Marrow Transplant, 35, 71, 10.1038/sj.bmt.1704749

Mohrmann, 1990, Neuropathologic findings after bone marrow transplantation: an autopsy study, Hum Pathol, 21, 630, 10.1016/S0046-8177(96)90010-6

Bleggi-Torres, 2000, Neuropathological findings after bone marrow transplantation: an autopsy study of 180 cases, Bone Marrow Transplant, 25, 301, 10.1038/sj.bmt.1702140

Bartynski, 2005, Variable incidence of cyclosporine and FK-506 neurotoxicity in hematopoeitic malignancies and marrow conditions after allogeneic bone marrow transplantation, Neurocrit Care, 3, 33, 10.1385/NCC:3:1:033

Chohan, 2003, Long-term outcomes of allogeneic stem cell transplant recipients after calcineurin inhibitor-induced neurotoxicity, Br J Haematol, 123, 110, 10.1046/j.1365-2141.2003.04550.x

Bartynski, 2001, Etiology of cortical and white matter lesions in cyclosporin-A and FK-506 neurotoxicity, AJNR Am J Neuroradiol, 22, 1901

Trullemans, 2001, Clinical findings and magnetic resonance imaging in severe cyclosporine-related neurotoxicity after allogeneic bone marrow transplantation, Eur J Haematol, 67, 94, 10.1034/j.1600-0609.2001.t01-1-00440.x

Bartynski, 2004, Pretransplantation conditioning influence on the occurrence of cyclosporine or FK-506 neurotoxicity in allogeneic bone marrow transplantation, AJNR Am J Neuroradiol, 25, 261

Zimmer, 1998, The effect of human leukocyte antigen disparity on cyclosporine neurotoxicity after allogeneic bone marrow transplantation, AJNR Am J Neuroradiol, 19, 601

Cohen, 1993, Reversible neurologic toxicity in patients treated with standard-dose fludarabine phosphate for mycosis fungoides and chronic lymphocytic leukemia, Ann Intern Med, 118, 114, 10.7326/0003-4819-118-2-199301150-00007

Spriggs, 1986, Fludarabine phosphate (NSC 312878) infusions for the treatment of acute leukemia: phase I and neuropathological study, Cancer Res, 46, 5953

Vidarsson, 2002, Progressive multifocal leukoencephalopathy after fludarabine therapy for low-grade lymphoproliferative disease, Am J Hematol, 70, 51, 10.1002/ajh.10085

Warrell, 1986, Phase I and II study of fludarabine phosphate in leukemia: therapeutic efficacy with delayed central nervous system toxicity, J Clin Oncol, 4, 74, 10.1200/JCO.1986.4.1.74

Mayer, 1994, Intensive postremission chemotherapy in adults with acute myeloid leukemia, N Engl J Med, 331, 896, 10.1056/NEJM199410063311402

Fyles, 1991, Long-term results of bone marrow transplantation for patients with AML, ALL and CML prepared with single dose total body irradiation of 500 cGy delivered with a high dose rate, Bone Marrow Transplant, 8, 453

Gupta, 2004, The role of allogeneic bone marrow transplantation in adult patients below the age of 55 years with acute lymphoblastic leukemia in first complete remission: a donor vs no donor comparison, Bone Marrow Transplant, 33, 397, 10.1038/sj.bmt.1704368

Kiss, 2003, Busulfan and cyclophosphamide as a preparative regimen for allogeneic blood and marrow transplantation in patients with non-Hodgkin’s lymphoma, Bone Marrow Transplant, 31, 73, 10.1038/sj.bmt.1703790

Gupta, 2005, Disease biology rather than age is the most important determinant of survival of patients > or = 60 years with acute myeloid leukemia treated with uniform intensive therapy, Cancer, 103, 2082, 10.1002/cncr.21006

Gupta, 2005, Nonmyeloablative stem cell transplantation for myelodysplastic syndrome or acute myeloid leukemia in patients 60 years or older, Biol Blood Marrow Transplant, 11, 764, 10.1016/j.bbmt.2005.06.006

Casey, 2000, Posterior reversible encephalopathy syndrome: utility of fluid-attenuated inversion recovery MR imaging in the detection of cortical and subcortical lesions, AJNR Am J Neuroradiol, 21, 1199

Hinchey, 1996, A reversible posterior leukoencephalopathy syndrome, N Engl J Med, 334, 494, 10.1056/NEJM199602223340803

Gooley, 1999, Estimation of failure probabilities in the presence of competing risks: new representations of old estimators, Stat Med, 18, 695, 10.1002/(SICI)1097-0258(19990330)18:6<695::AID-SIM60>3.0.CO;2-O

Kaplan, 1958, Nonparametric estimation from incomplete observations, J Am Stat Assoc, 53, 457, 10.1080/01621459.1958.10501452

Wong, 2003, Tacrolimus-associated posterior reversible encephalopathy syndrome after allogeneic haematopoietic stem cell transplantation, Br J Haematol, 122, 128, 10.1046/j.1365-2141.2003.04447.x

Erer, 1996, CsA-associated neurotoxicity and ineffective prophylaxis with clonazepam in patients transplanted for thalassemia major: analysis of risk factors, Bone Marrow Transplant, 18, 157

Lucey, 1990, Cyclosporin toxicity at therapeutic blood levels and cytochrome P-450 IIIA, Lancet, 335, 11, 10.1016/0140-6736(90)90137-T

Thompson, 1984, Association between cyclosporin neurotoxicity and hypomagnesaemia, Lancet, 2, 1116, 10.1016/S0140-6736(84)91556-3

Thông tin
Thông tin xuất bản

Biology of Blood and Marrow Transplantation

Tập 13

1369-1379

Thông tin tác giả